Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists

Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists

US Patent 9815790 · Granted Nov 14, 2017

Estimated economic value: $77,530,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Common sense reasoning for deepfake detection2025
Collections of peptides, peptide agents, and methods of use thereof2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a fac2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Immunoglobulins and uses thereof2024
Immunoglobulins and uses thereof2024
Pyridine N-oxide derivatives useful as factor XIa inhibitors2023
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine t2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023